← Back to Clinical Trials
Recruiting NCT05057676

Autoimmune Intervention Mastery Course Study

Trial Parameters

Condition Multiple Sclerosis
Sponsor Terry L. Wahls
Study Type INTERVENTIONAL
Phase N/A
Enrollment 400
Sex ALL
Min Age 18 Years
Max Age 100 Years
Start Date 2021-12-01
Completion 2027-12-01
Interventions
Immediate Autoimmune Intervention Mastery Course (AIM)Immediate Question and Answer sessions. (AIM Q and A sessions)Delayed Autoimmune Intervention Mastery Course (delayed AIM course)

Brief Summary

The goal of this project is to critically evaluate the effectiveness of using an online program to improve diet and self-care in patients with multiple sclerosis (MS), clinically isolated syndrome (CIS), fibromyalgia, post acute sequela of covid, and cancer in remission with persisting fatigue.

Eligibility Criteria

Inclusion Criteria: * self-reported multiple sclerosis * self-reported clinically isolated syndrome OR self-reported post-acute sequelae of COVID (PASC), also known as long COVID, with a confirmed laboratory test of COVID-19 infection, persisting fatigue and neuropsychiatric symptoms for longer than 6 months after confirmation of COVID diagnosis, OR self-reported diagnosis of fibromyalgia as documented by their treating specialist or primary care provider, Exclusion Criteria: \-

Related Trials